Testosterone, Bioavailable and Total, Includes Sex Hormone-Binding Globulin (Adult Females, Children, or Individuals on Testosterone-Suppressing Hormone Therapy) TSTBCF

Method(s) Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry/Electrochemiluminescent Immunoassay
Specimen Required
Collect

5 mL gold (SST) top tube or green (sodium or lithium heparin)

Transport

Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum refrigerated to a Standard Transport Tube. (Min: 0.8 mL)

Remarks

This test is suggested for women and children due to an improved sensitivity of testosterone by LC-MS/MS.

Stability

After separation from cells: Ambient: 24 hours; Refrigerated: 1 week; Frozen: 6 months

Unacceptable Conditions

EDTA plasma

Schedule Daily
Billing Code 5010648
CPTCode 84403; 84270; 84402
Notes Collect between 6-10 AM.
Preferred Specimen Collection Device(s)
Reference Interval
 
Sex Hormone Binding Globulin
AgeMaleFemale
1-30 days13-85 nmol/L14-60 nmol/L
31-364 days70-250 nmol/L60-215 nmol/L
1-3 years50-180 nmol/L60-190 nmol/L
4-6 years45-175 nmol/L55-170 nmol/L
7-9 years28-190 nmol/L35-170 nmol/L
10-12 years23-160 nmol/L17-155 nmol/L
13-15 years13-140 nmol/L11-120 nmol/L
16-17 years10-60 nmol/L19-145 nmol/L
18-49 years17-56 nmol/L25-122 nmol/L
50 years and older19-76 nmol/L17-125 nmol/L
Tanner Stage I26-186 nmol/L30-173 nmol/L
Tanner Stage II22-169 nmol/L16-127 nmol/L
Tanner Stage III13-104 nmol/L12-98 nmol/L
Tanner Stage IV11-60 nmol/L14-151 nmol/L
Tanner Stage V11-71 nmol/L23-165 nmol/L
 
Testosterone LC-MS, Bioavailable
AgeFemaleAgeMale
1-6 yearsLess than 1.3 ng/dL1-6 yearsLess than 1.3 ng/dL
7-9 years0.3-5.0 ng/dL7-9 years0.3-2.8 ng/dL
10-11 years0.4-9.6 ng/dL10-11 years0.1-17.9 ng/dL
12-13 years1.7-18.8 ng/dL12-13 years1.4-288.0 ng/dL
14-15 years3.0-22.6 ng/dL14-15 years9.5-337.0 ng/dL
16-17 years3.3-28.6 ng/dL16-17 years35.0-509.0 ng/dL
18-30 years2.2-20.6 ng/dL18 years and older130-680 ng/dL
31-40 years4.1-25.5 ng/dLTanner Stage I0.3-13.0 ng/dL
41-51 years2.8-16.5 ng/dLTanner Stage II0.3-59.0 ng/dL
Postmenopausal1.5-9.4 ng/dLTanner Stage III1.9-296.0 ng/dL
Tanner Stage I0.3-5.5 ng/dLTanner Stage IV40.0-485.0 ng/dL
Tanner Stage II1.2-15.0 ng/dLTanner Stage V124.0-596.0 ng/dL
Tanner Stage III3.8-28.0 ng/dL  
Tanner Stage IV2.8-39.0 ng/dL  
Tanner Stage V2.5-23.0 ng/dL  
 
Testosterone Free (Adult Females, Children, or Individuals on Testosterone-Suppressing Hormone Therapy)
AgeFemaleAgeMale
1-6 yearsLess than 0.6 pg/mL1-6 yearsLess than 0.6 pg/mL
7-9 years0.6-18 pg/mL7-9 years0.1-0.9 pg/mL
10-11 years0.1-3.5 pg/mL10-11 years0.1-6.3 pg/mL
12-13 years0.9-6.8 pg/mL12-13 years0.5-98.0 pg/mL
14-15 years1.2-7.5 pg/mL14-15 years3-138.0 pg/mL
16-17 years1.2-9.9 pg/mL16-17 years38.0-173.0 pg/mL
18-30 years0.8-7.4 pg/mL18 years and older47-244 pg/mL
31-40 years1.3-9.2 pg/mLTanner Stage ILess than or equal to 3.7 pg/mL
41-51 years1.1-5.8 pg/mLTanner Stage II0.3-21 pg/mL
Postmenopausal0.6-3.8 pg/mLTanner Stage III1.0-98.0 pg/mL
Tanner Stage ILess than 2.2 pg/mLTanner Stage IV35.0-169.0 pg/mL
Tanner Stage II0.4-4.5 pg/mLTanner Stage V41.0-239.0 pg/mL
Tanner Stage III1.3-7.5 pg/mL  
Tanner Stage IV1.1-15.5 pg/mL  
Tanner Stage V0.8-9.2 pg/mL  
 
Testosterone (Adult Females, Children, or Individuals on Testosterone-Suppressing Hormone Therapy)
AgeFemaleMale
Premature (26-28 weeks)5-16 ng/dL59-125 ng/dL
Premature (31-35 weeks)5-22 ng/dL37-198 ng/dL
Newborn20-64 ng/dL75-400 ng/dL
1-5 monthsLess than 20 ng/dL14-363 ng/dL
6-24 monthsLess than 9 ng/dLLess than 37 ng/dL
2-3 yearsLess than 20 ng/dLLess than 15 ng/dL
4-5 yearsLess than 30 ng/dLLess than 19 ng/dL
6-7 yearsLess than 7 ng/dLLess than 13 ng/dL
8-9 years1-11 ng/dL2-8 ng/dL
10-11 years3-32 ng/dL2-165 ng/dL
12-13 years6-50 ng/dL3-619 ng/dL
14-15 years6-52 ng/dL31-733 ng/dL
16-17 years9-58 ng/dL158-826 ng/dL
18-39 years9-55 ng/dL300-1080 ng/dL
40-59 years9-55 ng/dL300-890 ng/dL
60 years and older5-32 ng/dL300-720 ng/dL
Premenopausal
(18 years and older)
9-55 ng/dLDoes Not Apply
Postmenopausal5-32 ng/dLDoes Not Apply
Tanner Stage I2-17 ng/dL2-15 ng/dL
Tanner Stage II5-40 ng/dL3-303 ng/dL
Tanner Stage III10-63 ng/dL10-851 ng/dL
Tanner Stage IV-V11-82 ng/dL162-847 ng/dL
No Appointment Necessary
Show All Locations >
12 Patient Service Centers in Central New York.

Test Directory

A B C D E F
G H I J K L
M N O P Q R
S T U V W X
Y Z # List >